• Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial

    المصدر: Nasdaq GlobeNewswire / 09 ديسمبر 2023 12:00:00   America/New_York

    N/A
شارك على،